Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
gender decrease » greater decrease (Expand Search), teer decrease (Expand Search)
related disease » related diseases (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
gender decrease » greater decrease (Expand Search), teer decrease (Expand Search)
related disease » related diseases (Expand Search)
-
19881
Data Sheet 10_Lactobacillus rhamnosus GG attenuates MASLD/MASH progression by modulating gut microbiota and metabolic pathways.zip
Published 2025“…Dysbiosis of the gut microbiota plays a significant role in chronic liver diseases, making probiotic treatment a focal point in MASLD research. …”
-
19882
Data Sheet 2_Lactobacillus rhamnosus GG attenuates MASLD/MASH progression by modulating gut microbiota and metabolic pathways.zip
Published 2025“…Dysbiosis of the gut microbiota plays a significant role in chronic liver diseases, making probiotic treatment a focal point in MASLD research. …”
-
19883
Data Sheet 9_Lactobacillus rhamnosus GG attenuates MASLD/MASH progression by modulating gut microbiota and metabolic pathways.zip
Published 2025“…Dysbiosis of the gut microbiota plays a significant role in chronic liver diseases, making probiotic treatment a focal point in MASLD research. …”
-
19884
Data Sheet 6_Lactobacillus rhamnosus GG attenuates MASLD/MASH progression by modulating gut microbiota and metabolic pathways.zip
Published 2025“…Dysbiosis of the gut microbiota plays a significant role in chronic liver diseases, making probiotic treatment a focal point in MASLD research. …”
-
19885
Data Sheet 1_Lactobacillus rhamnosus GG attenuates MASLD/MASH progression by modulating gut microbiota and metabolic pathways.zip
Published 2025“…Dysbiosis of the gut microbiota plays a significant role in chronic liver diseases, making probiotic treatment a focal point in MASLD research. …”
-
19886
Data Sheet 3_Lactobacillus rhamnosus GG attenuates MASLD/MASH progression by modulating gut microbiota and metabolic pathways.zip
Published 2025“…Dysbiosis of the gut microbiota plays a significant role in chronic liver diseases, making probiotic treatment a focal point in MASLD research. …”
-
19887
Data Sheet 7_Lactobacillus rhamnosus GG attenuates MASLD/MASH progression by modulating gut microbiota and metabolic pathways.zip
Published 2025“…Dysbiosis of the gut microbiota plays a significant role in chronic liver diseases, making probiotic treatment a focal point in MASLD research. …”
-
19888
Data Sheet 8_Lactobacillus rhamnosus GG attenuates MASLD/MASH progression by modulating gut microbiota and metabolic pathways.zip
Published 2025“…Dysbiosis of the gut microbiota plays a significant role in chronic liver diseases, making probiotic treatment a focal point in MASLD research. …”
-
19889
Data Sheet 1_Global, regional, and national burden and trends of reproductive-aged male and female infertility from 1990–2021.docx
Published 2025“…</p>Methods<p>Data on the prevalence and disability-adjusted life years (DALYs) related to infertility among 15–49 years men and women from 1990 to 2021 were obtained from the Global Burden of Disease (GBD) Study 2021. …”
-
19890
Data Sheet 5_Lactobacillus rhamnosus GG attenuates MASLD/MASH progression by modulating gut microbiota and metabolic pathways.zip
Published 2025“…Dysbiosis of the gut microbiota plays a significant role in chronic liver diseases, making probiotic treatment a focal point in MASLD research. …”
-
19891
Data Sheet 4_Lactobacillus rhamnosus GG attenuates MASLD/MASH progression by modulating gut microbiota and metabolic pathways.zip
Published 2025“…Dysbiosis of the gut microbiota plays a significant role in chronic liver diseases, making probiotic treatment a focal point in MASLD research. …”
-
19892
Data Sheet 2_Global, regional, and national burden and trends of reproductive-aged male and female infertility from 1990–2021.xlsx
Published 2025“…</p>Methods<p>Data on the prevalence and disability-adjusted life years (DALYs) related to infertility among 15–49 years men and women from 1990 to 2021 were obtained from the Global Burden of Disease (GBD) Study 2021. …”
-
19893
Data Sheet 1_Associations between composite systemic inflammation indicators(CAR, CLR, SII, AISI, SIRI, and CALLY) and metabolic dysfunction-associated fatty liver disease (MAFLD):...
Published 2025“…Background<p>The redefinition from nonalcoholic fatty liver disease (NAFLD) to metabolic dysfunction-associated fatty liver disease (MAFLD) highlights metabolic dysfunction’s central role. …”
-
19894
-
19895
Supplementary Material for: Efficacy and Safety of Intravitreal Faricimab in Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema, and Retinal Vein Occlusion: A Met...
Published 2024“…Faricimab was associated with a significantly higher reduction in CSFT in DME and RVO eyes but not in nAMD eyes. …”
-
19896
-
19897
-
19898
5.HT<sub>1A</sub> binding difference between known cause of death (KCOD) controls and SIDS.
Published 2025“…A) When SIDS is compared to PostKCOD controls only, the hypoglossal nucleus (HG) shows a significant increase in binding in SIDS compared to controls while the nucleus of the solitary tract (NTS) and medial accessory olive (MAO) show a significant age-vs-diagnosis interaction. …”
-
19899
Supplementary file 1_Elevated butyric acid and histamine in feces and serum as an indicator of onset of necrotic enteritis in broiler chickens.docx
Published 2025“…Background<p>Clostridium perfringens (CP) induced necrotic enteritis (NE) is an economically significant intestinal disease of broiler chickens. …”
-
19900
Table 1_Elevated butyric acid and histamine in feces and serum as an indicator of onset of necrotic enteritis in broiler chickens.xlsx
Published 2025“…Background<p>Clostridium perfringens (CP) induced necrotic enteritis (NE) is an economically significant intestinal disease of broiler chickens. …”